COMMUNIQUÉS West-GlobeNewswire

Atara Biotherapeutics to Participate in Three Upcoming Immuno-Oncology Conferences

22/03/2018 - 21:30

SOUTH SAN FRANCISCO, Calif., March 22, 2018 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA ), a leading off-the-shelf T-cell immunotherapy company developing novel treatments for patients with cancer, [...]

Progenics Pharmaceuticals Announces Three-Month Extension of PDUFA Date for AZEDRA® (iobenguane I 131)

22/03/2018 - 21:15

NEW YORK, March 22, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX ), an oncology company developing innovative medicines and imaging analysis technology for targeting and treating cancer, [...]

Caladrius Biosciences Reports 2017 Fourth Quarter and Year End Financial Results

22/03/2018 - 21:05

BASKING RIDGE, N.J., March 22, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS ) (“Caladrius” or the “Company”), a development-stage biopharmaceutical company with multiple technology platforms [...]

Leap Therapeutics Announces Proposed Public Offering of Common Stock

22/03/2018 - 21:05

CAMBRIDGE, Mass., March 22, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (NASDAQ: LPTX ), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that it has [...]

Cesca Therapeutics Announces Financial Results for the Transition Period July 1, 2017 to December 31, 2017, and Provides Corporate Update

22/03/2018 - 21:05

RANCHO CORDOVA, Calif., March 22, 2018 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ: KOOL ), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced [...]

Marrone Bio Innovations to Report Fourth Quarter and Full Year 2017 Financial Results on Thursday, March 29th at 2:00 p.m. Pacific time

22/03/2018 - 21:05

DAVIS, Calif., March 22, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ), (MBI) a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and [...]

Medigus Ltd Announces Fourth Quarter and Fiscal Year 2017 Financial Results

22/03/2018 - 21:05

OMER, Israel, March 22, 2018 (GLOBE NEWSWIRE) -- Medigus Ltd. (“Medigus” or the “Company”) (NASDAQ: MDGS ) (TASE: MDGS ), a medical device company developing minimally invasive endosurgical tools and an innovator in [...]

OrthoPediatrics Corp. Introduces PediFlex™ Advanced Surgical System

22/03/2018 - 21:05

WARSAW, Ind., March 22, 2018 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (NASDAQ: KIDS ), a company exclusively focused on advancing the field of pediatric orthopedics, is pleased to announce the introduction of PediFlex [...]

Altimmune to Participate at the H.C. Wainwright Global Life Sciences Conference

22/03/2018 - 21:01

GAITHERSBURG, Md., March 22, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT ), a clinical-stage immunotherapeutics company, announced today that Bill Enright, President and Chief Executive Officer, will provide a [...]

HTG Molecular Diagnostics Reports Fourth Quarter and Full Year 2017 Results

22/03/2018 - 21:01

Revenue increased 442% and 188%, respectively, compared to the three and twelve month periods in the prior year driven by development efforts supporting Pharma clinical programs TUCSON, Ariz., March 22, 2018 (GLOBE [...]

iCAD Reports Fourth Quarter and Full-Year 2017 Financial Results

22/03/2018 - 21:01

Fourth quarter total revenues increased 14% year-over-year; total revenues increased 22% excluding MRI asset sale Conference call today at 4:30 p.m. ET NASHUA, N.H., March 22, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ [...]

CareDx Reports Fourth Quarter and FY2017 Financial Results

22/03/2018 - 21:01

47 Transplantation Centers Offering AlloSure 9 Centers Enrolled in K-OAR BRISBANE, Calif., March 22, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (NASDAQ: CDNA ), a molecular diagnostics company focused on the discovery, [...]

La Jolla Pharmaceutical Company Announces Launch of GIAPREZA™ (angiotensin II) in the United States

22/03/2018 - 21:01

SAN DIEGO, March 22, 2018 (GLOBE NEWSWIRE) -- La Jolla Pharmaceutical Company (Nasdaq: LJPC ) today announced that GIAPREZA™ (angiotensin II), injection for intravenous infusion, is now commercially available. In [...]

Title21’s CEO Lynn Fischer Shares Her Career Pivot into Healthcare Technology on THE MENTORS RADIO SHOW

22/03/2018 - 19:46

PLEASANTON, Calif., March 22, 2018 (GLOBE NEWSWIRE) -- Co-founder and CEO of Title21 Health Solutions ( www.Title21.com ) Lynn Fischer will share her purpose-driven career story on The MENTORS RADIO SHOW this weekend. [...]

CyberFuels, Inc. Announces Completion of GSA Application and award of CAGE number

22/03/2018 - 18:27

PALM BEACH, Fla., March 22, 2018 (GLOBE NEWSWIRE) -- EncounterCare Solutions, Inc. (Pink Sheets:ECSL) wholly owned subsidiary CyberFuels is pleased to announce that it has completed the registration process for [...]

Establishment Labs Receives IDE Approval from U.S. FDA to Initiate Clinical Trial of Motiva Implants®

22/03/2018 - 18:24

NEW YORK, March 22, 2018 (GLOBE NEWSWIRE) -- Establishment Labs Holdings Inc., a global medical device company focused on breast aesthetics and reconstruction technologies with a strong emphasis on product development [...]

Sharecare CEO Jeff Arnold to Interview Walmart’s David Hoke at The Conference Board’s Employee Health Care Conference in San Diego

22/03/2018 - 18:17

ATLANTA, March 22, 2018 (GLOBE NEWSWIRE) -- Sharecare, the digital health company helping people manage all their health in one place, today announced that its co-founder, chairman and CEO Jeff Arnold will interview [...]

IBA SA : TRANSPARENCY NOTIFICATION

22/03/2018 - 17:36

IBA - TRANSPARENCY NOTIFICATION Louvain-la-Neuve, Belgium, March 22, 2018, 17.35 - IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces that it [...]

IBA SA : NOTIFICATION DE TRANSPARENCE

22/03/2018 - 17:36

IBA - NOTIFICATION DE TRANSPARENCE Louvain-la-Neuve, Belgique, 22 mars 2018, 17.35 - IBA (Ion Beam Applications SA), le premier fournisseur mondial de solutions de protonthérapie pour le traitement du cancer, annonce [...]